Vitiligo

A recent study aimed to investigate the risk of myocardial infarction, cerebrovascular accident, peripheral vascular disease, and pulmonary embolism in patients with vitiligo.

Povorcitinib is being evaluated for non-segmental vitiligo, hidradenitis suppurativa, prurigo nodularis, asthma, and chronic spontaneous urticaria.

The study uncovered sexual dimorphism in melanocyte stem cell migration rates due to UVB-induced inflammatory responses in mice.

The recommendations were recently published in JAMA Dermatology following an extensive literature review, article grading, and a review of research questions.

While additional, larger studies are necessary, researchers said dietary choices may help reduce dependency on pharmacological methods.

The social and psychological effects of vitiligo, particularly concerning gender disparities, have come to the forefront in recent literature.

Several posters presented at the American Academy of Dermatology Annual Meeting explored the topic of skin tone bias related to vitiligo in Google and internet search platforms.

Iltefat Hamzavi, MD, reviews late-breaking data at AAD on upadacitinib as monotherapy.

Maggi Ahmed, MD, PhD, demonstrated superior pigmentation outcomes and reduced CD8+ T cell numbers in her recent research results.

Dive into a complex case report of a 29-year-old African American male patient with Fitzpatrick skin type V with a 6-month reported history of vitiligo on his lips.

The combination therapy did not yield any effect in patients with non-segmental vitiligo and prompts additional large studies prior to conclusive efficacy.

Researchers noted that this study's findings are consistent with prior epidemiologic data.

For a patient with vitiligo who is concerned about potential flares, what might you recommend avoiding?

People with vitiligo in the US face burdensome health care expenses, including expenses seemingly unrelated to the condition, according to 1 study.

People with vitiligo face a higher risk of retinal detachment, according to a study in Taiwan.

Learn more about the in-depth topics covered in the January 2024 topical treatments for vitiligo supplement of Dermatology Times.

Seemal Desai, MD, highlighted the challenges and opportunities to best serve patients seeking solutions for acne scars, melasma, vitiligo, and cosmetic concerns.

Innovative practice pearls for both vitiligo and atopic dermatitis treatment were shared with nearly 200 clinicians to put into practice at the virtual Revolutionizing Vitiligo and Revolutionizing Atopic Dermatitis Conferences.

Researchers said this data is demonstrative of VYN201's positive effects on multiple vitiligo-related biomarkers.

Researchers compared the quality of life, anxiety, depression, sleep disturbance, and other associated factors between patients with alopecia areata and vitiligo.

Researchers analyzed the characteristics of Wood's lamp and reflective confocal laser scanning microcopy in guiding vitiligo staging.

As 2023 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in vitiligo this year.

Delve into challenging vitiligo cases and solutions discussed at recent Dermatology Times Case Based Roundtable events across the country.

Investigators evaluated vitiligo punch grafting effectiveness on stable vitiligo lesions.

Sarkar spoke with Dermatology Times after the ReV conference to discuss her session on vitiligo stigma.

Delve into challenging vitiligo cases and solutions discussed at recent Dermatology Times Case Based Roundtable events across the country.

An expert in dermatology reviews the case of a 10-year-old male with segmental vitiligo, shedding light on the panel's gaps in understanding this complex condition. The conversation explores the treatment challenges and the emotional impact on patients, particularly those of Asian or Indian descent.

Karan Lal DO, MS, FAAD presents the case of a 51-year-old African American male with vitiligo, exploring insurance challenges, treatment options such as topical ruxolitinib, Excimer, and phototherapy, and strategies for setting and managing patient treatment response expectations.

An expert in dermatology presents the case of a 23-year-old male patient presenting with unstable vitiligo. He delves into treatment options available for managing this condition, shedding light on the nuances and optimal scenarios for each therapeutic agent.

James Song, MD, FAAD, presents the case of a 14-year-old male patient seeking vitiligo treatment. He emphasizes the significance of addressing mental health concerns alongside managing the physical symptoms of this condition. He further discusses possible approaches to treat the patient's depigmented patches, particularly considering that this patient was diagnosed with segmental vitiligo.